Web-Based Dissemination of Evidence-Based Prevention to U.S. Military

通过网络向美国军方传播循证预防

基本信息

项目摘要

DESCRIPTION (provided by applicant): This Phase I SBIR grant application requests six months of funding to develop and feasibility test an innovative Web-based distribution channel for increasing the dissemination, adoption, implementation, and sustainability (DAIS) of evidence-based substance use prevention programs to United States military personnel. Substance use and abuse, particularly heavy alcohol and tobacco use, remain problematic in the military and adversely affect health, safety, military fitness levels, deployment readiness, active service, and increase health care costs. Significant progress has been made in the development and testing of evidence-based prevention programs (EBPPs); however, these programs are underutilized in military settings. A systematic mechanism is needed to disseminate EBPPs to key military decision-makers. Alcohol and Drug Control Officers (ADCOs) and similar personnel oversee the provision of a variety of programs and services to military personnel and are important decision-makers in military settings. Indeed, ADCOs and related personnel have great potential to become dissemination agents and program champions for EBPPs. Accordingly, the goal of this proposed project is to develop a Web-based distribution channel for ADCOs and related personnel that will facilitate the DAIS of EBPPs to military personnel. In the proposed Phase I project, we will develop prototypes of the key components of the Web-based distribution channel, which will include informational resources on evidence- based programs, training and technical assistance resources to facilitate the implementation and sustainability of programs, a marketing toolkit, an electronic newsletter, and a decision support mechanism. Prevention programs for the workplace will be featured. Prior to prototype development, we will conduct key informant interviews with ADCOs from the Army to obtain input regarding ways to optimize the distribution channel components to meet the needs of local Army personnel. Following prototype development, we will conduct focus groups with ADCOs currently serving new recruits and young adult Army personnel to obtain their feedback regarding the feasibility and utility of the components in facilitating the DAIS of EBPPs. In Phase II, we will fully develop and populate the Web-based components and conduct a large-scale effectiveness trial involving the five branches of the U.S. military (Army, Navy, Marine Corps, Air Force, and Coast Guard). PUBLIC HEALTH RELEVANCE: This project involves the development and feasibility testing of a technology-based distribution channel for increasing the dissemination, adoption, implementation, and sustainability (DAIS) of evidence-based substance use prevention programs to service providers for United States Military personnel. Incorporating input from Alcohol and Drug Control Officers (ADCOs) from the US Army, as well as from an expert military psychologist, a prototype of a multi-component, Web-based distribution channel will be developed and populated with information about evidence-based workplace prevention programming. The feasibility and utility of the components will be focus group tested among ADCOs currently serving new recruits and young adult Army personnel in terms of the utility of the components in facilitating the DAIS of evidence-based programs.
描述(由申请人提供):本一阶段SBIR赠款申请要求六个月的资金来开发和可行性测试,一种基于网络的创新分销渠道,用于增加对美国军事人员的投放,采用,实施,实施和可持续性(DAI)的预防预防计划。药物使用和滥用,尤其是大量酒精和烟草的使用,在军事中仍然有问题,并对健康,安全,军事健身水平,部署准备,积极服务以及增加医疗保健成本产生了不利影响。在循证预防计划(EBPPS)的开发和测试中取得了重大进展。但是,在军事环境中,这些计划不足。需要系统的机制将EBPP传播到关键的军事决策者。酒精和药物控制官员(ADCO)和类似人员监督为军事人员提供各种计划和服务,是军事环境中的重要决策者。确实,ADCO和相关人员具有成为EBPPS的传播代理和计划冠军的巨大潜力。因此,这个拟议项目的目标是开发一个基于网络的ADCO和相关人员的分销渠道,该渠道将促进EBPP的Dais向军事人员提供。在拟议的第一阶段项目中,我们将开发基于Web的分销渠道的关键组成部分的原型,其中包括基于证据的计划,培训和技术援助资源的信息资源,以促进计划的实施和可持续性,营销工具包,电子通讯以及决策支持机制。将介绍工作场所的预防计划。在进行原型开发之前,我们将对陆军的ADCO进行关键的线人访谈,以获取有关优化分销渠道组件以满足当地陆军人员需求的方法的意见。在原型开发之后,我们将与目前为新兵和年轻成年军人人员服务的ADCO进行焦点小组,以获取有关组件在促进EBPPS的可行性和实用性的反馈。在第二阶段,我们将充分开发和填充基于网络的组件,并进行大规模的效力试验,涉及美国军方的五个分支机构(陆军,海军,海军陆战队,空军和海岸警卫队)。 公共卫生相关性:该项目涉及基于技术的分销渠道的开发和可行性测试,以增加对基于证据的药物使用预防计划的传播,采用,实施和可持续性(DAI),以为美国军事人员提供服务提供商。将开发和填写有关基于Web的分销渠道的专家军事心理学家的饮酒和药物控制官(ADCO)的意见,以及专业的军事心理学家,将开发和填充有关基于证据的工作场所预防计划的信息。组件的可行性和实用性将在目前为新兵和年轻成年军人人员服务的ADCO中进行焦点小组,以促进基于证据的计划的DAI,以促进组件的实用性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher Williams其他文献

Christopher Williams的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher Williams', 18)}}的其他基金

Using Digital Health Technology to Prevent Bullying and Cyberbullying among Elementary School Students
利用数字健康技术预防小学生欺凌和网络欺凌
  • 批准号:
    10822435
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
Effect of CX4945 in tamoxifen resistant BCa
CX4945 在他莫昔芬耐药 BCa 中的作用
  • 批准号:
    10673636
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
Effect of CX4945 in tamoxifen resistant BCa
CX4945 在他莫昔芬耐药 BCa 中的作用
  • 批准号:
    10228560
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
Effect of CX4945 in tamoxifen resistant BCa
CX4945 在他莫昔芬耐药 BCa 中的作用
  • 批准号:
    10458662
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
An Evidence-based Approach for Bullying Prevention
预防欺凌的循证方法
  • 批准号:
    10192438
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
A High School Program for Preventing Prescription Drug Abuse
预防处方药滥用的高中计划
  • 批准号:
    9980826
  • 财政年份:
    2017
  • 资助金额:
    $ 12.52万
  • 项目类别:
A High School Program for Preventing Prescription Drug Abuse
预防处方药滥用的高中计划
  • 批准号:
    10226253
  • 财政年份:
    2017
  • 资助金额:
    $ 12.52万
  • 项目类别:
Induction of a tumor-hostile breast cancer microenvironment by metformin
二甲双胍诱导肿瘤不利的乳腺癌微环境
  • 批准号:
    8855851
  • 财政年份:
    2015
  • 资助金额:
    $ 12.52万
  • 项目类别:
Induction of a tumor-hostile breast cancer microenvironment by metformin
二甲双胍诱导肿瘤不利的乳腺癌微环境
  • 批准号:
    9058123
  • 财政年份:
    2015
  • 资助金额:
    $ 12.52万
  • 项目类别:
Innovative Positive Juvenile Justice Tools for Youth Courts
青年法庭创新的积极少年司法工具
  • 批准号:
    8713202
  • 财政年份:
    2014
  • 资助金额:
    $ 12.52万
  • 项目类别:

相似国自然基金

面向救援与疏散的危化品储运灾害事故情景推演与应急态势评估方法
  • 批准号:
    52374208
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
源于随机行人碰撞事故边界反求的头部损伤评价准则及风险预测
  • 批准号:
    52372348
  • 批准年份:
    2023
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
多入口下穿隧道合流区域交通事故演化机理与自解释调控方法
  • 批准号:
    52302437
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
聚变堆真空室内失水事故射流闪蒸特性研究
  • 批准号:
    12305183
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
燃料样品辐照流道堵塞事故演化机理及全堆响应研究
  • 批准号:
    12375178
  • 批准年份:
    2023
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目

相似海外基金

The Effect of Emergency Department and After-Emergency Department Analgesic Treatment on Pediatric Long Bone Fracture Outcomes
急诊科和急诊科术后镇痛治疗对小儿长骨骨折预后的影响
  • 批准号:
    10410483
  • 财政年份:
    2018
  • 资助金额:
    $ 12.52万
  • 项目类别:
The Effect of Emergency Department and After-Emergency Department Analgesic Treatment on Pediatric Long Bone Fracture Outcomes
急诊科和急诊科术后镇痛治疗对小儿长骨骨折预后的影响
  • 批准号:
    9764396
  • 财政年份:
    2018
  • 资助金额:
    $ 12.52万
  • 项目类别:
The Effect of Emergency Department and After-Emergency Department Analgesic Treatment on Pediatric Long Bone Fracture Outcomes
急诊科和急诊科术后镇痛治疗对小儿长骨骨折预后的影响
  • 批准号:
    10174978
  • 财政年份:
    2018
  • 资助金额:
    $ 12.52万
  • 项目类别:
Designer covalent heterobivalent inhibitors to prevent IgE-dependent allergic reactions
设计共价异二价抑制剂来预防 IgE 依赖性过敏反应
  • 批准号:
    10553716
  • 财政年份:
    2014
  • 资助金额:
    $ 12.52万
  • 项目类别:
Unobtrusive measurement of sleep disordered breathing in the home
在家中对睡眠呼吸障碍进行不显眼的测量
  • 批准号:
    8629561
  • 财政年份:
    2010
  • 资助金额:
    $ 12.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了